AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 155 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -98.9% | 1,595 | -98.7% | 0.00% | – |
| Q1 2022 | $89,000 | -68.2% | 123,997 | +0.1% | 0.00% | – |
| Q4 2021 | $280,000 | +12.0% | 123,867 | +42.9% | 0.00% | – |
| Q3 2021 | $250,000 | -45.3% | 86,696 | -28.0% | 0.00% | – |
| Q2 2021 | $457,000 | +13.1% | 120,488 | +1.0% | 0.00% | – |
| Q1 2021 | $404,000 | +21.0% | 119,302 | 0.0% | 0.00% | – |
| Q4 2020 | $334,000 | +11.7% | 119,302 | 0.0% | 0.00% | – |
| Q3 2020 | $299,000 | -81.5% | 119,302 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $1,620,000 | +105.6% | 119,302 | +14.8% | 0.00% | +100.0% |
| Q1 2020 | $788,000 | +28.8% | 103,902 | +7.2% | 0.00% | 0.0% |
| Q4 2019 | $612,000 | +28.8% | 96,902 | -20.0% | 0.00% | 0.0% |
| Q3 2019 | $475,000 | -18.9% | 121,102 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $586,000 | -10.9% | 121,102 | +50.8% | 0.00% | 0.0% |
| Q1 2019 | $658,000 | +48.2% | 80,302 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $444,000 | +7.5% | 80,302 | +71.6% | 0.00% | – |
| Q3 2018 | $413,000 | -33.3% | 46,800 | -24.6% | 0.00% | -100.0% |
| Q2 2018 | $619,000 | +23.3% | 62,070 | +17.8% | 0.00% | 0.0% |
| Q1 2018 | $502,000 | -35.9% | 52,670 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $783,000 | -17.2% | 52,670 | +9.5% | 0.00% | 0.0% |
| Q3 2017 | $946,000 | +36.9% | 48,100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $691,000 | +56.0% | 48,100 | -0.0% | 0.00% | 0.0% |
| Q1 2017 | $443,000 | +14.8% | 48,101 | +29.7% | 0.00% | 0.0% |
| Q4 2016 | $386,000 | +14.9% | 37,100 | 0.0% | 0.00% | – |
| Q3 2016 | $336,000 | +59.2% | 37,100 | +31.6% | 0.00% | – |
| Q2 2016 | $211,000 | -44.3% | 28,200 | -32.9% | 0.00% | -100.0% |
| Q1 2016 | $379,000 | +4.1% | 42,042 | +49.3% | 0.00% | 0.0% |
| Q4 2015 | $364,000 | +19.3% | 28,162 | -10.8% | 0.00% | – |
| Q3 2015 | $305,000 | +1.7% | 31,565 | +8.3% | 0.00% | – |
| Q2 2015 | $300,000 | – | 29,147 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,031,283 | $95,485,000 | 5.72% |
| GREAT POINT PARTNERS LLC | 3,510,073 | $47,667,000 | 3.81% |
| Logos Global Management LP | 1,200,000 | $16,296,000 | 3.26% |
| DAFNA Capital Management LLC | 762,666 | $10,357,000 | 2.99% |
| Baupost Group | 15,000,000 | $203,700,000 | 2.54% |
| Nantahala Capital Management | 6,101,111 | $82,853,000 | 2.50% |
| Abrams Capital Management | 5,656,462 | $76,815,000 | 2.48% |
| Novo Holdings A/S | 1,987,506 | $26,990,000 | 1.74% |
| Stanley-Laman Group, Ltd. | 316,933 | $4,304,000 | 1.04% |
| Integral Health Asset Management, LLC | 250,000 | $3,395,000 | 1.02% |